SAMXACINE

This brand name is authorized in Nigeria.

Active ingredients

The drug SAMXACINE contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 5E8K9I0O4U - CIPROFLOXACIN
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-2022	Solution for injection/infusion	Samxacine Infusion INJ_SOL 200 mg/100 mL 1 X 100ML	Samxacine Infusion C4-2022 Samxacin CIPROFLOXACIN 200MG/100ML DRUG ANTIBIOTIC CIPROFLOXACIN 200MG/100ML INJECTION 1 X 100ML PRESCRIPTION ONLY MEDICINE TREATMENT OF BACTERIAL INFECTION CAUSED BY SUCEPTIBLE MICROORGANISM SAM SUNNY PHARM & STORES LIMITED. NIGERIA SHIJIAZHUANG NO. 4 PHARMA. CO. LTD. CHINA 10/22/2022 21/10/2027	22/10/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-2022